Simplex Trading’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-200
| Closed | – | – | 8774 |
|
|
2020
Q1 | $0 | Buy |
+200
| New | +$862 | ﹤0.01% | 8636 |
|
|
2019
Q3 | – | Sell |
-11,707
| Closed | -$58.4K | – | 8228 |
|
|
2019
Q2 | $72K | Buy |
11,707
+6,089
| +108% | +$29.4K | ﹤0.01% | 4517 |
|
|
2019
Q1 | $26K | Buy |
+5,618
| New | +$25.4K | ﹤0.01% | 5545 |
|
|
2018
Q4 | – | Sell |
-4,473
| Closed | -$22.8K | – | 8244 |
|
|
2018
Q3 | $28K | Buy |
4,473
+2,411
| +117% | +$18.5K | ﹤0.01% | 5715 |
|
|
2018
Q2 | $16K | Sell |
2,062
-19,692
| -91% | -$150K | ﹤0.01% | 6063 |
|
|
2018
Q1 | $162K | Buy |
21,754
+6,044
| +38% | +$40.2K | 0.01% | 1404 |
|
|
2017
Q4 | $93K | Sell |
15,710
-9,102
| -37% | -$55.3K | ﹤0.01% | 1863 |
|
|
2017
Q3 | $182K | Buy |
24,812
+22,544
| +994% | +$143K | 0.01% | 1254 |
|
|
2017
Q2 | $15K | Buy |
+2,268
| New | +$16.7K | ﹤0.01% | 3614 |
|
|
2017
Q1 | – | Sell |
-517
| Closed | -$5.16K | – | 7099 |
|
|
2016
Q4 | $4K | Sell |
517
-3,425
| -87% | -$25.3K | ﹤0.01% | 4636 |
|
|
2016
Q3 | $24K | Buy |
+3,942
| New | +$23.8K | ﹤0.01% | 2816 |
|
|
2016
Q2 | – | Sell |
-6,018
| Closed | -$29.1K | – | 6741 |
|
|
2016
Q1 | $26K | Buy |
6,018
+2,509
| +72% | +$11.2K | ﹤0.01% | 2564 |
|
|
2015
Q4 | $21K | Buy |
3,509
+3,445
| +5,383% | +$22.6K | ﹤0.01% | 2664 |
|
|
2015
Q3 | $0 | Sell |
64
-1,946
| -97% | -$14.9K | ﹤0.01% | 6499 |
|
|
2015
Q2 | $14K | Sell |
2,010
-1,445
| -42% | -$8.74K | ﹤0.01% | 2802 |
|
|
2015
Q1 | $20K | Buy |
+3,455
| New | +$21.7K | ﹤0.01% | 2349 |
|
Other funds holding PGNX
Simplex Trading's PGNX Position: Q2 2020 in Review
Simplex Trading sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 200 shares.
Simplex Trading first reported a position in PGNX in Q1 2015 and held it in 16 quarters. The position peaked at $182K in Q3 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.
- Simplex Trading reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
- Simplex Trading sold 200 Progenics Pharmaceuticals Inc shares in Q2 2020.
- Simplex Trading first reported a position in Progenics Pharmaceuticals Inc in Q1 2015 and held it in 16 quarters.
- Simplex Trading's Progenics Pharmaceuticals Inc position peaked at $182K in Q3 2017.
- 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.
Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.